NasdaqCM - Nasdaq Real Time Price USD

Arcadia Biosciences, Inc. (RKDA)

Compare
2.8000 -0.0100 (-0.36%)
As of 12:47 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,482.0000
5,330.0000
7,418.0000
6,780.0000
8,034.0000
Cost of Revenue
3,440.0000
3,300.0000
6,101.0000
8,708.0000
5,199.0000
Gross Profit
2,042.0000
2,030.0000
1,317.0000
-1,928.0000
2,835.0000
Operating Expense
16,331.0000
15,895.0000
16,545.0000
26,827.0000
24,427.0000
Operating Income
-14,289.0000
-13,865.0000
-15,228.0000
-28,755.0000
-21,592.0000
Net Non Operating Interest Income Expense
585.0000
695.0000
289.0000
-20.0000
-47.0000
Other Income Expense
5,143.0000
13.0000
4,125.0000
12,643.0000
15,489.0000
Pretax Income
-8,561.0000
-13,157.0000
-10,814.0000
-16,132.0000
-6,150.0000
Tax Provision
7.0000
8.0000
14.0000
2.0000
-124.0000
Net Income Common Stockholders
-5,827.0000
-13,981.0000
-15,376.0000
-14,660.0000
-4,655.0000
Diluted NI Available to Com Stockholders
-5,827.0000
-13,981.0000
-15,376.0000
-14,660.0000
-4,655.0000
Basic EPS
-4.17
-11.30
-25.65
-27.60
-18.80
Diluted EPS
-4.17
-11.30
-25.65
-27.60
-18.80
Basic Average Shares
1,362.4840
1,236.9340
599.3890
532.0150
248.9750
Diluted Average Shares
1,362.4840
1,236.9340
599.3890
532.0150
248.9750
Total Operating Income as Reported
-10,398.0000
-13,938.0000
-14,007.0000
-35,526.0000
-12,778.0000
Total Expenses
19,771.0000
19,195.0000
22,646.0000
35,535.0000
29,626.0000
Net Income from Continuing & Discontinued Operation
-5,827.0000
-13,981.0000
-15,376.0000
-14,660.0000
-4,655.0000
Normalized Income
-12,488.7700
-13,554.6050
-15,017.5700
-17,067.5400
-19,123.7690
Interest Income
585.0000
695.0000
289.0000
--
--
Interest Expense
--
--
--
20.0000
47.0000
Net Interest Income
585.0000
695.0000
289.0000
-20.0000
-47.0000
EBIT
-14,289.0000
-13,865.0000
-15,228.0000
-28,755.0000
-6,103.0000
EBITDA
-14,137.0000
-13,578.0000
-14,749.0000
-27,710.0000
-5,441.0000
Reconciled Cost of Revenue
3,440.0000
3,300.0000
6,101.0000
8,708.0000
5,199.0000
Reconciled Depreciation
152.0000
287.0000
479.0000
1,045.0000
662.0000
Net Income from Continuing Operation Net Minority Interest
-8,568.0000
-13,160.0000
-10,592.0000
-14,660.0000
-4,655.0000
Total Unusual Items Excluding Goodwill
4,963.0000
395.0000
4,430.0000
3,298.0000
14,749.0000
Total Unusual Items
4,963.0000
395.0000
4,430.0000
3,298.0000
14,749.0000
Normalized EBITDA
-19,100.0000
-13,973.0000
-19,179.0000
-31,008.0000
-20,190.0000
Tax Rate for Calcs
0.0002
0.0000
0.0000
0.0003
0.0000
Tax Effect of Unusual Items
1,042.2300
0.3950
4.4300
890.4600
280.2310
12/31/2020 - 5/15/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BOF BranchOut Food Inc.
1.8100
-5.24%
 
SOWG Sow Good Inc.
3.7000
-6.09%
 
ABVE Above Food Ingredients Inc.
0.6200
+19.53%
 
ORIS Oriental Rise Holdings Limited
6.15
+0.33%
 
BU.TO Burcon NutraScience Corporation
0.1450
0.00%
 
SNAX Stryve Foods, Inc.
0.9244
+0.74%
 
FAMI Farmmi, Inc.
0.2643
-1.93%
 
QO8.F FitLife Brands, Inc.
28.30
+0.35%
 
Z1L0.DU Leroy Seafood Group ASA
8.25
-0.60%
 
GCHE.ME Public Joint Stock Company "Cherkizovo Group"
2,650.50
+0.06%